أعرض في EDS

Supplementary Table from Health-Related Quality of Life Outcomes in Patients with Resected Epidermal Growth Factor Receptor–Mutated Non–Small Cell Lung Cancer Who Received Adjuvant Osimertinib in the Phase III ADAURA Trial

التفاصيل البيبلوغرافية
العنوان: Supplementary Table from Health-Related Quality of Life Outcomes in Patients with Resected Epidermal Growth Factor Receptor–Mutated Non–Small Cell Lung Cancer Who Received Adjuvant Osimertinib in the Phase III ADAURA Trial
المؤلفون: Yi-Long Wu, Roy S. Herbst, Masahiro Tsuboi, Nenad Medic, Dakshayini Kulkarni, Lingmin Zeng, Shinji Atagi, Frances A. Shepherd, Manuel Domine, Laura Bonanno, Filippo de Marinis, Chong-Jen Yu, Charuwan Akewanlop, Kye Young Lee, Shanqing Li, Shun Lu, Huu Vinh Vu, Terufumi Kato, Sang-We Kim, Konstantin Laktionov, Christian Grohe, Thomas John, Jonathan W. Goldman, Margarita Majem
بيانات النشر: American Association for Cancer Research (AACR), 2023.
سنة النشر: 2023
الوصف: Supplementary Table from Health-Related Quality of Life Outcomes in Patients with Resected Epidermal Growth Factor Receptor–Mutated Non–Small Cell Lung Cancer Who Received Adjuvant Osimertinib in the Phase III ADAURA Trial
DOI: 10.1158/1078-0432.22488165
URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::268f88dd02803a42a55e9889ed150369
https://doi.org/10.1158/1078-0432.22488165
Rights: OPEN
رقم الانضمام: edsair.doi.dedup.....268f88dd02803a42a55e9889ed150369
قاعدة البيانات: OpenAIRE
الوصف
DOI:10.1158/1078-0432.22488165